Total debt rose to $41.6M (D/E 0.35) while cash stood at $52.7M, but the current ratio fell to 1.18 from 1.77 in 2024Q1, and deferred revenue declined 19.3% sequentially to $74.5M, signaling a thinning liquidity cushion and potential subscription headwinds.
Evolv Technologies Holdings, Inc. (EVLV) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 149.41M | 151.3M | 121.45M | 175.84M | 292.58M | 331.12M | 10.31M | 20.31M |
| Cash & Short-Term Investments | 62.63M | 69.03M | 51.94M | 118.82M | 230.12M | 307.7M | 4.7M | 17.34M |
| Cash Only | 52.7M | 49.15M | 37.02M | 67.16M | 229.78M | 307.49M | 4.7M | 17.34M |
| Short-Term Investments | 9.94M | 19.89M | 14.93M | 51.66M | 337K | 206K | 0 | 0 |
| Accounts Receivable | 39.58M | 47.06M | 29.19M | 26.32M | 34.77M | 7.94M | 1.4M | 984K |
| Days Sales Outstanding | 96.15 | 117.73 | 102.58 | 119.45 | 240.74 | 123.83 | 106.87 | 61.44 |
| Inventory | 8.66M | 9.32M | 16.96M | 9.51M | 10.26M | 2.89M | 2.74M | 1.36M |
| Days Inventory Outstanding | 37.25 | 48.17 | 138.89 | 74.48 | 72.95 | 54.47 | 286.28 | 93.56 |
| Other Current Assets | 8.85M | 25.89M | 7.51M | 5.95M | 4.5M | 2.29M | 628K | 100K |
| Total Non-Current Assets | 152.62M | 153.11M | 146.61M | 122.88M | 55.53M | 31.74M | 11.05M | 4.09M |
| Property, Plant & Equipment | 140.39M | 139.82M | 137.65M | 114.12M | 46.38M | 23.78M | 9.32M | 3.69M |
| Fixed Asset Turnover | 1.23x | 1.04x | 0.75x | 0.70x | 1.14x | 0.98x | 0.51x | 1.59x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 7M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 381K | 0 | 376K | 84K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 12.23M | 13.28M | 8.58M | 1.68M | 9.15M | 7.95M | 1.73M | 407K |
| Total Assets | 302.02M | 304.41M | 268.06M | 298.72M | 348.12M | 362.86M | 21.36M | 24.4M |
| Asset Turnover | 0.56x | 0.48x | 0.39x | 0.27x | 0.15x | 0.06x | 0.22x | 0.24x |
| Asset Growth % | 49.54% | 13.56% | -10.26% | -14.19% | -4.06% | 1599.17% | -12.48% | - |
| Total Current Liabilities | 126.85M | 122.98M | 96.71M | 82.05M | 59.13M | 24.33M | 12.12M | 9.33M |
| Accounts Payable | 12.25M | 9.77M | 10.49M | 17.4M | 18.19M | 6.04M | 4.44M | 2.52M |
| Days Payables Outstanding | 46.65 | 50.51 | 85.91 | 136.32 | 129.4 | 113.94 | 463.25 | 173.88 |
| Short-Term Debt | 0 | 0 | 11.11M | 0 | 10M | 2M | 227K | 3.42M |
| Deferred Revenue (Current) | 302.61M | 74.92M | 64.51M | 47.68M | 18.27M | 6.6M | 3.72M | 1.55M |
| Other Current Liabilities | 0 | 16.85M | 2.72M | 14M | 9.14M | 7.07M | 1.39M | 711K |
| Current Ratio | 1.18x | 1.23x | 1.26x | 2.14x | 4.95x | 13.61x | 0.85x | 2.18x |
| Quick Ratio | 1.11x | 1.15x | 1.08x | 2.03x | 4.78x | 13.49x | 0.62x | 2.03x |
| Cash Conversion Cycle | 86.75 | 115.38 | 155.57 | 57.61 | 184.29 | 64.36 | -70.1 | -18.89 |
| Total Non-Current Liabilities | 56.32M | 62.01M | 53.7M | 70.35M | 62M | 48.25M | 18.05M | 73.58M |
| Long-Term Debt | 28.74M | 28.6M | 0 | 0 | 19.68M | 7.95M | 16.43M | 0 |
| Capital Lease Obligations | 41.67M | 10.65M | 12.33M | 0 | 892K | 0 | 132K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 83K | 6.04M | 21.11M | 46.54M | 23.73M | 37.83M | 1M | 73.27M |
| Total Liabilities | 183.16M | 184.99M | 150.41M | 152.4M | 121.13M | 72.58M | 30.16M | 82.91M |
| Total Debt | 41.57M | 42.24M | 25.64M | 1.39M | 31.69M | 9.95M | 16.79M | 3.65M |
| Net Debt | -11.13M | -6.91M | -11.37M | -65.77M | -198.09M | -297.55M | 12.09M | -13.7M |
| Debt / Equity | 0.35x | 0.35x | 0.22x | 0.01x | 0.14x | 0.03x | - | - |
| Debt / EBITDA | -8.42x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.25x | - | - | - | - | - | - | - |
| Interest Coverage | -0.44x | -18.10x | - | -161.39x | -120.90x | -0.79x | -62.70x | -24.49x |
| Total Equity | 118.86M | 119.42M | 117.65M | 146.32M | 226.99M | 290.27M | -8.81M | -58.51M |
| Equity Growth % | 8.73% | 1.51% | -19.6% | -35.54% | -21.8% | 3395.2% | 84.94% | - |
| Book Value per Share | 0.66 | 0.71 | 0.75 | 0.98 | 1.58 | 1.90 | -0.06 | -0.41 |
| Total Shareholders' Equity | 118.86M | 119.42M | 117.65M | 146.32M | 226.99M | 290.27M | -8.81M | -58.51M |
| Common Stock | 18K | 18K | 16K | 15K | 15K | 14K | 1K | 23K |
| Retained Earnings | -402.11M | -387.8M | -354.66M | -298.46M | -192.21M | -105.8M | -93.88M | -66.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -113K | -141K | -32K | -53K | -10K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying EVLV stock.
As of 2025, Evolv Technologies Holdings, Inc. (EVLV) had total assets of $304.4M including $151.3M in current assets.
Evolv Technologies Holdings, Inc. (EVLV) carries total debt of $42.2M, offset by $69.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Evolv Technologies Holdings, Inc. (EVLV) has total shareholders' equity (book value) of $119.4M ($0.71 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Evolv Technologies Holdings, Inc. (EVLV) reported a current ratio of 1.23x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Cash runway and efficacy concerns
Metrics are mathematically derived from official filings.
Balance Sheet Stabilizes Amid Revenue Growth
Total assets have held near $302-305M over the last three quarters, while equity improved to $118.9M in 2026Q2, suggesting a stabilizing balance sheet despite ongoing losses.
The balance sheet appears to have stabilized after a volatile 2025, with total assets hovering around $302-305M since 2025Q3. Equity has recovered from $92.7M in 2025Q2 to $118.9M in 2026Q2, driven by a reduction in total liabilities from $202.1M to $183.2M. This stabilization, coupled with revenue growth of 34.4% year-over-year, suggests that the company is managing its capital structure while scaling, though the persistent negative retained earnings of -$402.1M indicate that losses continue to erode book value.
Leverage Rises but Remains Manageable
Total debt increased to $41.6M in 2026Q2 from $14.3M a year earlier, lifting D/E to 0.35, yet this remains low relative to peers like OSIS at 0.72.
Evolv's debt has more than doubled over the past year, from $14.3M in 2025Q2 to $41.6M in 2026Q2, while the debt-to-equity ratio rose from 0.15 to 0.35. This increase appears strategic, likely to fund growth initiatives and bridge the gap to profitability, but it also introduces refinancing risk given the company's negative operating margins. However, the absolute debt level is modest relative to total assets of $302M, and the D/E remains below the peer average, suggesting that leverage is not yet a constraint.
Asset Base Shifts Toward Deployed Hardware
PP&E net rose to $140.4M in 2026Q2, representing 46.5% of total assets, while goodwill remains zero, indicating an asset-heavy model with no acquisition-related intangibles.
The asset mix is increasingly dominated by property, plant, and equipment, which grew from $122.2M in 2024Q2 to $140.4M in 2026Q2, now comprising nearly half of total assets. This reflects the company's strategy of deploying hardware as part of its TaaS model, which requires significant upfront investment. The absence of goodwill suggests that growth has been organic, but the high PPE concentration implies that depreciation will continue to weigh on earnings, and the assets may be subject to impairment if technology shifts.
Equity Quality Eroded by Persistent Losses
Retained earnings worsened to -$402.1M in 2026Q2, while equity of $118.9M is supported by paid-in capital, indicating that accumulated losses exceed half of total assets.
The equity base is of low quality, as retained earnings have deteriorated from -$306.6M in 2024Q2 to -$402.1M in 2026Q2, reflecting cumulative losses that outpace any capital raises. The positive equity balance is entirely attributable to contributed capital, which suggests that shareholders' equity is a function of external funding rather than internal profitability. This pattern is typical of growth-stage companies, but it underscores the reliance on future profitability to justify the current capital structure.
Liquidity Buffer Thins Despite Cash Stabilization
Cash rose to $52.7M in 2026Q2, but the current ratio fell to 1.18 from 1.77 in 2024Q1, indicating a shrinking liquidity cushion relative to short-term obligations.
While cash has stabilized around $49-56M over the last three quarters, the current ratio has declined from 1.77 in 2024Q1 to 1.18 in 2026Q2, signaling that current liabilities are growing faster than current assets. This suggests that the company's ability to cover short-term obligations is weakening, and with operating losses persisting, the $52.7M cash balance may only provide a limited runway. Investors should monitor whether the company can achieve cash-flow break-even before needing additional capital.
Deferred Revenue Masks Subscription Health
Deferred revenue fell to $74.5M in 2026Q2 from $92.3M in 2026Q1, a 19.3% sequential decline, which may indicate slowing upfront collections or a shift in contract terms.
The sharp drop in deferred revenue from $92.3M to $74.5M in one quarter is notable, as it could signal that the company is recognizing revenue faster or that new subscription bookings are not generating the same level of upfront cash. This trend warrants investigation, as a sustained decline in deferred revenue might suggest weakening demand or a change in the mix toward hardware sales, which would have implications for future revenue visibility and cash flow stability.